Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects.

Ling Yang,Qi Shen,Chao Hu,Ying Wang,Xiaohong Zhu,Shiqing Shu,Zhu Luo

Drug design, development and therapy（2022）

引用 1|浏览3

暂无评分

摘要

Pharmacokinetic and safety profiles of imrecoxib in elderly healthy subjects indicated that no dose adjustment should be required for elderly population.

查看译文

关键词

cyclooxygenase-2 inhibitor,elderly,imrecoxib,pharmacokinetics,safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要